Center for Technology Commercialization

UWM Research Foundation

Program: UWM Research Foundation

Wearable Neurorehabilitation Technology for Stroke Recovery

Technology Sectors: ,

The Opportunity: Improving Hand Function After Stroke Many stroke survivors experience persistent hand impairment that limits independence and quality of life. Rehabilitation can be time-intensive, costly, and difficult to sustain after formal therapy ends. The Technology & Current Status TheraBracelet® is a wrist-worn neurorehabilitation device that delivers imperceptible vibratory stimulation designed to enhance hand function

Program: Medical College of Wisconsin UWM Research Foundation

Next-Generation Anxiety Therapeutics

Technology Sectors:

The Opportunity: New Approaches to Treating Anxiety Disorders Anxiety disorders are common, yet existing treatments, including SSRIs, SNRIs, and benzodiazepines, may provide incomplete relief, act slowly, cause unwanted side effects, or raise concerns about dependence. The Technology & Current Status This technology is focused on developing a novel class of therapeutics for anxiety disorders based

Program: UWM Research Foundation

Novel Therapeutics for Memory and Brain Health

Technology Sectors:

The Opportunity: New Approaches to Memory Loss and Cognitive Decline Memory impairment and cognitive decline affect millions of people through aging, Alzheimer’s disease, and other neurological disorders. Existing treatments provide limited benefits, creating demand for new therapeutics that improve cognitive function while maintaining favorable safety and tolerability. The Technology & Current Status This technology consists

Program: UWM Research Foundation

Multi-Dose IV Delivery Platform

Technology Sectors: ,

The Opportunity: Reducing IV Medication Errors and Infection Risk | Intravenous medication administration is essential to modern healthcare, yet frequent IV-line access creates opportunities for medication errors, contamination, and bloodstream infections. Current practice often requires multiple syringes, repeated line manipulations, and complex workflows that increase risk in emergency, critical care, and other high-pressure clinical settings.

Program: UWM Research Foundation

AI-Enabled Drug Discovery Platform

Technology Sectors: ,

The Opportunity: Unlocking Previously “Undruggable” Diseases | Protein-protein interactions (PPIs) drive many of the biological pathways involved in cancer, autoimmune disorders, and other serious diseases. Yet many PPIs remain difficult to target because of their complexity and dynamic behavior. As pharmaceutical companies increasingly invest in AI-enabled drug discovery, there is growing demand for platforms that

Program: UWM Research Foundation

Respiratory Therapeutic for Chemical Exposure Emergencies

Technology Sectors:

The Opportunity: Addressing a Critical Preparedness Gap | Chlorine is one of the most widely used industrial chemicals in the world and is a leading cause of toxic inhalation exposure. Accidental releases, transportation incidents, industrial accidents, and intentional misuse can result in serious lung injury, respiratory distress, and death. Despite the ongoing risk, there is

Program: UWM Research Foundation

Low‑Cost Surface Alloying for Copper & Brass Castings

Technology Sectors:

Improving corrosion resistance and safety in critical metal components This technology enables foundries to produce safer, more durable copper and brass components by selectively upgrading surface performance. It improves corrosion resistance and reduces lead leaching using existing foundry processes—delivering higher‑quality products without changing bulk alloys or investing in new equipment.

Program: UWM Research Foundation

Secure‑by‑Design AI for Edge Devices

Technology Sectors:

Protecting real‑world AI before it’s exploited As AI moves onto cameras, robots, and sensors, security must be built in—not bolted on. By embedding protection directly into edge operation, this on‑device software helps defend against malicious attacks, reducing risk and enabling broader, safer adoption of AI beyond controlled environments.